![](/img/cover-not-exists.png)
Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients
Busch, A., Zeh, D., Janzen, V., Mügge, L.-O., Wolf, D., Fingerhut, L., Hahn-Ast, C., Maurer, O., Brossart, P., von Lilienfeld-Toal, M.Volume:
177
Language:
english
Journal:
Clinical & Experimental Immunology
DOI:
10.1111/cei.12343
Date:
August, 2014
File:
PDF, 834 KB
english, 2014